This inventor holds 18 USPTO granted patents and 2 published patent applications and 10 EPO patents, primarily in Nucleic Acid Amplification. Top assignee: Life Technologies Corporation. Active years: 2016-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Amesbury, CA (US) (2019)
- Amesbury, MA (US) (2016 - 2023)
Company Filing History:
Years Active: 2016-2026
Areas of Expertise:
Title: **Innovative Achievements of Rachel Kasinskas**
Introduction
Rachel Kasinskas, an accomplished inventor based in Amesbury, MA, has made significant contributions to the field of nucleic acid amplification. With a remarkable portfolio of 16 patents, her work continues to push the boundaries of biotechnology and genetic research.
Latest Patents
Rachel's latest patents focus on advanced methods and systems for nucleic acid amplification. These innovations include techniques for partially denaturing nucleic acids and amplifying them without full denaturation. A notable aspect of her work involves employing enzymes that catalyze homologous recombination alongside polymerases to enhance the amplification process. Additionally, her methods are designed to be performed in a single reaction vessel, eliminating the need for complex compartmentalization. Rachel's inventive approach extends to the generation of localized populations of immobilized clonal amplicons, further advancing the technology in this area.
Career Highlights
Rachel is currently affiliated with Life Technologies Corporation, a leader in biotechnology solutions. Her role in the company allows her to collaborate on cutting-edge projects, and she has consistently contributed to the advancement of genetic amplification technologies throughout her career. Her innovative research has garnered attention and respect within the scientific community.
Collaborations
Throughout her journey, Rachel has worked alongside esteemed colleagues such as Bin Li and Kai Qin Lao. These collaborations have played a significant role in enriching her research and ensuring the successful development and implementation of her groundbreaking inventions.
Conclusion
Rachel Kasinskas exemplifies the spirit of innovation in biotechnology through her impressive patent portfolio and collaborative efforts. Her dedication to advancing nucleic acid amplification technologies is evident in her contributions to Life Technologies Corporation and the broader scientific community. As she continues to innovate, her work holds the promise of future breakthroughs in genetic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile